VolitionRx Limited (VNRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VolitionRx Limited on September 15, 2026, covering events occurring on September 9, 2026. The Company is a Delaware corporation with its principal executive offices in Henderson, Nevada, and its common stock trades on NYSE American under the symbol "VNRX".
Key Financial Metrics and Capital Structure
The filing details specific equity transactions related to the conversion of senior secured convertible promissory notes issued to Lind Global Asset Management XII LLC ("Lind").
- Conversion Event 1: On September 2, 2026, the Company issued 706,214 shares of common stock to satisfy a $250,000 conversion obligation.
- Conversion Event 2: On September 10, 2026, the Company issued 707,236 shares of common stock to satisfy a $215,000 conversion obligation.
- Total Shares Issued: 1,413,450 shares were issued in connection with these conversions.
- Outstanding Shares: As of September 14, 2026, there were 27,903,326 shares of common stock issued and outstanding.
The filing does not provide data regarding revenue, profit, cash flow, operating margins, total debt, or liquidity positions.
Material Changes
The primary material change reported is the increase in outstanding common stock due to the conversion of debt obligations under a Securities Purchase Agreement (SPA) originally dated May 15, 2025, and amended on January 7, 2026. The transactions were executed without public offering, general solicitation, or paid commissions, relying on exemptions under Section 3(a)(9) or Section 4(a)(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the unregistered sale of equity securities. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the total principal amount of the senior secured convertible promissory notes held by Lind Global Asset Management XII LLC to assess remaining debt obligations.
- Confirm the conversion price per share implied by the recent transactions ($250,000 / 706,214 shares and $215,000 / 707,236 shares) to evaluate potential dilution.
- Review the amended SPA dated January 7, 2026, for terms regarding future conversion triggers or interest accrual.
- Check subsequent filings for updated cash flow statements to determine the Company's liquidity position following these debt conversions.